Cape Ann Savings Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,249
Closed -$778K 89
2021
Q2
$778K Sell
2,249
-698
-24% -$211K 0.49% 51
2021
Q1
$824K Sell
2,947
-55
-2% -$14.8K 0.59% 44
2020
Q4
$735K Buy
+3,002
New +$774K 0.53% 49
2020
Q2
$860K Buy
+3,214
New +$966K 0.73% 37
2019
Q3
$472K Buy
2,031
+525
+35% +$122K 0.55% 44
2019
Q2
$353K Buy
1,506
+52
+4% +$12K 0.41% 47
2019
Q1
$343K Hold
1,454
0.41% 46
2018
Q4
$472K Buy
1,454
+25
+2% +$7.98K 0.58% 42
2018
Q3
$505K Buy
1,429
+15
+1% +$5.16K 0.6% 40
2018
Q2
$506K Buy
+1,414
New +$398K 0.63% 40
2017
Q4
$431K Buy
+1,353
New +$434K 0.54% 42
2017
Q2
$353K Sell
1,303
-107
-8% -$28.3K 0.47% 45
2017
Q1
$386K Buy
1,410
+40
+3% +$11.3K 0.52% 44
2016
Q4
$380K Buy
1,370
+585
+75% +$173K 0.53% 44
2016
Q3
$246K Buy
+785
New +$232K 0.35% 59
2015
Q3
Sell
-650
Closed -$263K 66
2015
Q2
$263K Hold
650
0.37% 61
2015
Q1
$274K Hold
650
0.38% 61
2014
Q4
$221K Hold
650
0.32% 65
2014
Q3
$215K Sell
650
-50
-7% -$16.5K 0.32% 63
2014
Q2
$221K Hold
700
0.32% 63
2014
Q1
$214K Buy
+700
New +$222K 0.35% 59

Other funds holding BIIB

Cape Ann Savings Bank's BIIB Position: Q3 2021 in Review

Cape Ann Savings Bank sold out of Biogen (BIIB) in Q3 2021, closing a stake of 2,249 shares — an estimated $778K sold.

Cape Ann Savings Bank first reported a position in BIIB in Q1 2014 and held it in 21 quarters. The position peaked at $860K in Q2 2020. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Cape Ann Savings Bank reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Cape Ann Savings Bank sold 2,249 Biogen shares in Q3 2021, an estimated $778K.
  • Cape Ann Savings Bank first reported a position in Biogen in Q1 2014 and held it in 21 quarters.
  • Cape Ann Savings Bank's Biogen position peaked at $860K in Q2 2020.
  • 1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Cape Ann Savings Bank's 13F filing for Q3 2021, filed 22 Nov 2021.